Anti-TNF agents target mucosal intercellular signaling in inflammatory bowel diseases: A common molecular mechanism of action of clinically effective Anti-TNF agents

被引：0
作者：
Atreya, Raja Narayana
Bartsch, Brigitte
Galle, Peter R.
Neurath, Markus F.
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A644 / A644
页数：1
相关论文
共 50 条
[21]   Factors Predicting Response to Anti-TNF Agents for Patients With Inflammatory Bowel Disease [J].
Yoon, Soon Man ;
Haritunians, Talin ;
Chhina, Sultan ;
Ye, Byong Duk ;
Shih, David Q. ;
Vasiliauskas, Eric ;
Ippoliti, Andrew ;
Targan, Stephan ;
Melmed, Gil Y. ;
McGovern, Dermot .
GASTROENTEROLOGY, 2016, 150 (04) :S49-S50
[22]   TNF and anti-TNF agents in Behcet's disease [J].
Calamia, KT .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 2) :S3-S3
[23]   Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)? [J].
Gisbert, Javier P. ;
Chaparro, Maria .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
[24]   THE EFFECT OF THERAPEUTIC ANTI-TNF AGENTS ON REVERSE SIGNALING VIA MEMBRANE TNF [J].
Symons, Antony ;
Renshaw, Blair ;
Parrelli, Joel ;
Sims, John .
ADVANCES IN TNF FAMILY RESEARCH, 2011, 691 :719-719
[25]   Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases [J].
Bharati D. Kochar ;
David Cheng ;
Tianxi Cai ;
Ashwin N. Ananthakrishnan .
Digestive Diseases and Sciences, 2022, 67 :5206-5212
[26]   Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases [J].
Kochar, Bharati D. ;
Cheng, David ;
Cai, Tianxi ;
Ananthakrishnan, Ashwin N. .
DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (11) :5206-5212
[27]   Cytomegalovirus, inflammatory bowel disease, and anti-TNFα [J].
Campos, Sara T. ;
Portela, Francisco A. ;
Tome, Luis .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (05) :645-650
[28]   Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease [J].
Gisbert, Javier P. ;
Chaparro, Maria A. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (09) :1426-1438
[29]   Anti-TNF therapeutic agents in inflammatory bowel disease: indications, side effects and management [J].
Cocq, P ;
Yazdanpannah, Y ;
Mesnard, B ;
Colombel, JF .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 :D61-D69
[30]   The efficiency of iron supplementation in inflammatory bowel disease patients treated with anti-TNF agents [J].
Kim, Su Young ;
Kim, Yoon Jae ;
Kim, Jung Ho ;
Chung, Jun-Won ;
Kwon, Kwang An ;
Kim, Kyoung Oh ;
Park, Dong Kyun .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 :473-473
12345